Valproic acid Completed Phase 2 Trials for Glycogen Storage Disease Type V Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03112889Sodium Valproate for GSDV